Longitudinal analysis between exhaled nitric oxide (FeNO), inflammatory markers (IM) in exhaled breath condensate (EBC), lung function, and control/severity of childhood asthma Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007
The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO ) Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004
Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC) Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease Year: 2006
High levels of fractional exhaled nitric oxide (FeNO) only reflect the degree of allergen sensitization in mild childhood asthma Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005
Exhaled NO (FENO) is superior to peak-flow monitoring in predicting exacerbation in asthmatics Source: Eur Respir J 2005; 26: Suppl. 49, 118s Year: 2005
Bronchial hyperresponsiveness (BHR) in children with allergic rhinitis (AR) and its relationship to exhaled nitric oxide (FeNO) Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
Exhaled nitric oxide (eNO) levels in asthmatic children: relation to atopy and airway responsiveness (AHR) Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004
The 3-nitrothyrozine and total nitrate/nitrite (TNN) levels in exhaled breath condensate (EBC) in patients with bronchial asthma (BA) Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
Relationship between exhaled nitric oxide (eNO), atopy and asthma in children. ISAAC-clermont-ferrand Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001
Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018
Exhaled nitric oxide (eNO) and acidity of exhaled breath condensate (EBC pH) of children with asthma, cystic fibrosis (CF) and healthy controls Source: Eur Respir J 2005; 26: Suppl. 49, 42s Year: 2005
Exhaled NO (eNO) as a screening test for asthma in children Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002
FeNO (fractional exhaled nitric oxide) measurements in pregnant asthmatic women. The long-term, intra-subject variability of FeNO in controlled asthma Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012
Prospective nitrite, nitrate and cys-leukotriene (cys-LTs ) measurements in EBC (exhaled breath condensate) in asthmatic children and relation to outcome during inhaled steroid (IS) reduction Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003
Nitrite/nitrate in exhaled breath condensate (EBC) of patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
Atopy but no bronchial hyperresponsiveness (BHR) is related to level of exhaled nitric oxide (FeNO) in children with allergic rhinitis Source: Annual Congress 2008 - Exercise-induced asthma, acute severe asthma and allergic rhinitis in children Year: 2008
FeNO Source: Annual Congress 2009 - PG11 Paediatric lung function testing - an interactive course Year: 2009
Benefit of inhaled corticosteroids (ICS) in asthmatic patients with bronchial hyperresponsiveness (BHR) to mannitol and low fractional exhaled nitric oxide (FeNO) levels Source: International Congress 2017 – Monitoring asthma control Year: 2017
Nitric oxide metabolites and total IgE in exhaled air condensate (EAC) of the patients with bronchial asthma (BA) and allergen exposure Source: Eur Respir J 2002; 20: Suppl. 38, 604s Year: 2002